Using a prospective cohort, reseearchers assessed the seroconversion rates and anti-SARS-CoV-2 spike protein antibody titers following the 1st and 2nd dose of BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in patients with cancer in U.S. and Europe from January to April 2021.
[Cancer Cell]
6445218 ZHJWLKTN items 1 apa 0 default asc 1 163633 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-a6e3b1e2eefe16ab9b704a78260cbac5%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZHJWLKTN%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Addeo%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-18%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAddeo%2C%20A.%2C%20Shah%2C%20P.%20K.%2C%20Bordry%2C%20N.%2C%20Hudson%2C%20R.%20D.%2C%20Albracht%2C%20B.%2C%20Marco%2C%20M.%20D.%2C%20Kaklamani%2C%20V.%2C%20Dietrich%2C%20P.-Y.%2C%20Taylor%2C%20B.%20S.%2C%20Simand%2C%20P.-F.%2C%20Patel%2C%20D.%2C%20Wang%2C%20J.%2C%20Labidi-galy%2C%20I.%2C%20Fertani%2C%20S.%2C%20Leach%2C%20R.%20J.%2C%20Sandoval%2C%20J.%2C%20Mesa%2C%20R.%2C%20Lathrop%2C%20K.%2C%20Mach%2C%20N.%2C%20%26amp%3B%20Shah%2C%20D.%20P.%20%282021%29.%20Immunogenicity%20of%20SARS-CoV-2%20messenger%20RNA%20Vaccines%20in%20Patients%20with%20Cancer.%20%3Ci%3ECancer%20Cell%3C%5C%2Fi%3E%2C%20%3Ci%3E0%3C%5C%2Fi%3E%280%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ccell.2021.06.009%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ccell.2021.06.009%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DZHJWLKTN%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immunogenicity%20of%20SARS-CoV-2%20messenger%20RNA%20Vaccines%20in%20Patients%20with%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfredo%22%2C%22lastName%22%3A%22Addeo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pankil%20K.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natacha%22%2C%22lastName%22%3A%22Bordry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20D.%22%2C%22lastName%22%3A%22Hudson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brenna%22%2C%22lastName%22%3A%22Albracht%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariagrazia%20Di%22%2C%22lastName%22%3A%22Marco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virginia%22%2C%22lastName%22%3A%22Kaklamani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre-Yves%22%2C%22lastName%22%3A%22Dietrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%20S.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre-Francois%22%2C%22lastName%22%3A%22Simand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darpan%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Intidhar%22%2C%22lastName%22%3A%22Labidi-galy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Fertani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%20J.%22%2C%22lastName%22%3A%22Leach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Sandoval%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruben%22%2C%22lastName%22%3A%22Mesa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Lathrop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Mach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dimpy%20P.%22%2C%22lastName%22%3A%22Shah%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222021-06-18%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ccell.2021.06.009%22%2C%22ISSN%22%3A%221535-6108%2C%201878-3686%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.cell.com%5C%2Fcancer-cell%5C%2Fabstract%5C%2FS1535-6108%2821%2900330-5%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-18T20%3A48%3A15Z%22%7D%7D%5D%7D
Addeo, A., Shah, P. K., Bordry, N., Hudson, R. D., Albracht, B., Marco, M. D., Kaklamani, V., Dietrich, P.-Y., Taylor, B. S., Simand, P.-F., Patel, D., Wang, J., Labidi-galy, I., Fertani, S., Leach, R. J., Sandoval, J., Mesa, R., Lathrop, K., Mach, N., & Shah, D. P. (2021). Immunogenicity of SARS-CoV-2 messenger RNA Vaccines in Patients with Cancer. Cancer Cell, 0(0). https://doi.org/10.1016/j.ccell.2021.06.009 Cite